A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2

This publication has 47 references indexed in Scilit:

• Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells
  Oncogene, 2003
• Lyn regulates the cell death response to ultraviolet radiation through c-Jun N terminal Kinase-dependent Fas ligand activation
  Experimental Cell Research, 2003
• Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
  New England Journal of Medicine, 2002
• Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
  Science, 2001
• Bcl-2 Independence of Flavopiridol-induced Apoptosis
  Published by Elsevier ,2000
• Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
  Science, 2000
• Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells
  Oncogene, 2000
• Transformation of Myeloid Leukemia Cells to Cytokine Independence by Bcr-Abl Is Suppressed by Kinase-defective Hck
  Published by Elsevier ,2000
• Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL
  The Journal of Experimental Medicine, 2000
• A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma Cells
  Published by Elsevier ,2000